TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Clearinghouse Agrees: Three Dyes, Hair Color Agent Are Carcinogens; Risk To Humans – Brown May 5, 1978
TCL Archive NCI Denies GAO Report That Backlog Still Exists, Says Most were Published As Research Results May 18, 1979
TCL Archive In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three March 12, 1976
TCL Archive In Brief: Murphy To Head Pediatric Oncology Group; DeVita To Receive ACCC Research Award May 1, 1992
